๐Ÿ“ก TrialPulse
ACTIVE NOT RECRUITINGPHASE1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

NCT07224399ยทBrightGene Bio-Medical Technology Co., Ltd.ยทsource: ClinicalTrials.gov โ†—ยทupdated 2026-10-19
Registry history
Events detected for this trial โ€” severity ร— confidence ร— recency
Neon
How to read the confidence score: 1.0 = observed โ€” the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal โ€” inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
trial seenhigh2026-10-19
null โ†’ {"status":"ACTIVE_NOT_RECRUITING","last_update_posted_at":"2026-10-19"}
Key dates
Start2025-10-09
Primary completion2026-07-17
Enrollment60actual
HealhtyOverweight or ObesityDRUG
Site map
Per-site markers colored by site status
Live map
unknownPharmaron CPC, IncBaltimore, United States